2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
15
Papillomavirus Infections
9
Uterine Cervical Neoplasms
7
Pancreatic Neoplasms
6
Breast Neoplasms
6
Ovarian Neoplasms
5
Prostatic Neoplasms
4
Neuroendocrine Tumors
4
Neoplasm Metastasis
4
Myasthenia Gravis
3
Multiple Myeloma
3
Melanoma
3
Lymphoma
3
Lung Neoplasms
3
Autoimmune Diseases
3
Thyroid Diseases
2
Pancreatic Cyst
2
Neuroblastoma
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
COVID-19
2
Brain Neoplasms
2
Abortion, Spontaneous
2
Interventions
eculizumab
3
ravulizumab
2
fludarabine
2
Cyclophosphamide
2
ublituximab
1
thymoglobulin
1
prednylidene
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Sugars
1
Rituximab
1
Prednisone
1
Plasma Exchange
1
Peripheral Blood Stem Cell Transplantation
1
Mitoxantrone
1
Melphalan
1
LFB-R603
1
Immunoglobulins, Intravenous
1
Etoposide
1
Data Collection
1
Cytarabine
1
Carmustine
1
Antilymphocyte Serum
1
Alleles
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuromyelitis Optica
×
Data Collection
×
Clear all
NCT06443333
2024-06-05
NIDBase
Xuanwu Hospital, Beijing
Unknown
7,000 enrolled